Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.

[1]  Sung Eun Kim,et al.  Co‐delivery of platelet‐derived growth factor (PDGF‐BB) and bone morphogenic protein (BMP‐2) coated onto heparinized titanium for improving osteoblast function and osteointegration , 2015, Journal of tissue engineering and regenerative medicine.

[2]  P. Fedak,et al.  Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling , 2015, Journal of Translational Medicine.

[3]  Conor J. Walsh,et al.  Drug and cell delivery for cardiac regeneration. , 2015, Advanced drug delivery reviews.

[4]  C. Vrints,et al.  The cellular immune system in the post-myocardial infarction repair process. , 2015, International journal of cardiology.

[5]  Kathy O. Lui,et al.  Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA. , 2014, Stem cell research.

[6]  N. Rosenthal,et al.  Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation. , 2014, Stem cell research.

[7]  Richard T. Lee,et al.  Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. , 2014, Stem cell research.

[8]  G. Xiang,et al.  Human Myocardial Pericytes: Multipotent Mesodermal Precursors Exhibiting Cardiac Specificity , 2014, Stem cells.

[9]  M. Tirrell,et al.  Protein Encapsulation via Polypeptide Complex Coacervation. , 2014, ACS macro letters.

[10]  N. Rosenthal,et al.  Preparing the ground for tissue regeneration: from mechanism to therapy , 2014, Nature Medicine.

[11]  N. Johnson,et al.  Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects. , 2014, Macromolecular bioscience.

[12]  A. Shah,et al.  High-frequency speckle tracking echocardiography in the assessment of left ventricular function and remodeling after murine myocardial infarction. , 2014, American journal of physiology. Heart and circulatory physiology.

[13]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[14]  Jin Gao,et al.  Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts. , 2013, Biomaterials.

[15]  M. Poddar,et al.  Sustained Release of Bone Morphogenetic Protein 2 via Coacervate Improves the Osteogenic Potential of Muscle‐Derived Stem Cells , 2013, Stem cells translational medicine.

[16]  K. Lee,et al.  Co-delivery of Vascular Endothelial Growth Factor and Angiopoietin-1 Using Injectable Microsphere/Hydrogel Hybrid Systems for Therapeutic Angiogenesis , 2013, Pharmaceutical Research.

[17]  N. Johnson,et al.  Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[18]  N. K. Mohtaram,et al.  Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors , 2013, Biomedical materials.

[19]  Yadong Wang,et al.  The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium. , 2013, Biomaterials.

[20]  K. Tobita,et al.  Human Pericytes for Ischemic Heart Repair , 2013, Stem cells.

[21]  M. Zile,et al.  β3 Integrin in Cardiac Fibroblast Is Critical for Extracellular Matrix Accumulation during Pressure Overload Hypertrophy in Mouse , 2012, PloS one.

[22]  I. Komuro,et al.  Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function. , 2012, American journal of physiology. Heart and circulatory physiology.

[23]  Yadong Wang,et al.  Therapeutic angiogenesis: controlled delivery of angiogenic factors. , 2012, Therapeutic delivery.

[24]  N. Frangogiannis,et al.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[25]  Li Qian,et al.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.

[26]  Jaesoon Choi,et al.  The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. , 2011, Biomaterials.

[27]  F. Lallemand,et al.  Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure , 2011, Circulation.

[28]  Chien-Wen Chen,et al.  Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis , 2011, Proceedings of the National Academy of Sciences.

[29]  N. Mason,et al.  A [polycation:heparin] complex releases growth factors with enhanced bioactivity. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Srinivas Madduri,et al.  Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. , 2010, Biomaterials.

[31]  Richard T. Lee,et al.  Protein Therapeutics for Cardiac Regeneration after Myocardial Infarction , 2010, Journal of cardiovascular translational research.

[32]  W. Daniel,et al.  Interleukin‐10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction , 2008, European journal of heart failure.

[33]  R. Hendel,et al.  Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. , 2001, American heart journal.

[34]  S. Nitter‐Hauge,et al.  Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure , 2001, Circulation.

[35]  J R Arrand,et al.  Heparin and heparan sulfate bind interleukin-10 and modulate its activity. , 2000, Blood.

[36]  B. Wandt,et al.  Echocardiographic assessment of ejection fraction in left ventricular hypertrophy , 1999, Heart.

[37]  P. Rudland,et al.  Interactions of putative heparin-binding domains of basic fibroblast growth factor and its receptor, FGFR-1, with heparin using synthetic peptides , 1998, Glycoconjugate Journal.

[38]  E. Radwanski,et al.  Pharmacodynamics of subcutaneous recombinant human interleukin‐10 in healthy volunteers , 1997, Clinical pharmacology and therapeutics.

[39]  R. Kloner,et al.  Echocardiographic and cardiac Doppler assessment of mice. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  M. O’Donnell,et al.  Internal displacement and strain imaging using ultrasonic speckle tracking , 1994, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[41]  W J Manning,et al.  In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. , 1994, The American journal of physiology.

[42]  Jin Gao,et al.  Design, synthesis, and biocompatibility of an arginine‐based polyester , 2012, Biotechnology progress.

[43]  H. Mohan.  Chapter-12 The Heart , 2005 .

[44]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[45]  M.A. Lubinski,et al.  Speckle tracking methods for ultrasonic elasticity imaging using short-time correlation , 1999, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.